Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
36
BGS Quote, Financials, Valuation and Earnings
Last price:
$4.21
Seasonality move
:
1.19%
Day range:
$3.99 - $4.25
52-week range:
$3.97 - $9.74
Dividend yield:
18.05%
P/E ratio:
--
P/S ratio:
0.18x
P/B ratio:
0.65x
Volume:
3.2M
Avg. volume:
3.2M
1-year change:
-54.24%
Market cap:
$335.9M
Revenue:
$1.9B
EPS (TTM):
-$2.66
Analysts' Opinion
-
Consensus RatingB&G Foods has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $5.50, B&G Foods has an estimated upside of 30.64% from its current price of $4.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $4.21.
Fair Value
-
According to the consensus of 7 analysts, B&G Foods has 30.64% upside to fair value with a price target of $5.50 per share.
BGS vs. S&P 500
-
Over the past 5 trading days, B&G Foods has overperformed the S&P 500 by 2.04% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
B&G Foods does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
B&G Foods revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter B&G Foods reported revenues of $425.4M.
Earnings Growth
-
B&G Foods earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter B&G Foods reported earnings per share of $0.01.
Enterprise value:
2.3B
EV / Invested capital:
--
Price / LTM sales:
0.18x
EV / EBIT:
20.50x
EV / Revenue:
1.21x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
19.24x
Price / Operating cash flow:
2.82x
Enterprise value / EBITDA:
12.00x
Gross Profit (TTM):
$403.2M
Return On Assets:
-6.54%
Net Income Margin (TTM):
-11.16%
Return On Equity:
-31.47%
Return On Invested Capital:
-7.77%
Operating Margin:
8.43%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $2.1B | $2B | $1.9B | $475.2M | $425.4M | |
| Gross Profit | $422.6M | $450.2M | $403.2M | $108.9M | $90.1M | |
| Operating Income | $211M | $231.6M | $194.1M | $55.2M | $35.8M | |
| EBITDA | $207.2M | $94.7M | -$33.9M | $7.7M | $58.8M | |
| Diluted EPS | -$0.44 | -$1.44 | -$2.66 | -$0.51 | $0.01 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $729.4M | $859.9M | $936.8M | $785.3M | $758.3M | |
| Total Assets | $3.7B | $3.8B | $3.8B | $3.4B | $3B | |
| Current Liabilities | $207.6M | $248.3M | $230.7M | $244.2M | $228.6M | |
| Total Liabilities | $2.9B | $2.9B | $2.9B | $2.6B | $2.4B | |
| Total Equity | $840.6M | $914M | $861.8M | $781.2M | $513.1M | |
| Total Debt | $2.3B | $2.3B | $2.3B | $2B | $2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $50.3M | $213.4M | $148.5M | $35.1M | $52.7M | |
| Cash From Investing | $5.2M | $26M | -$30M | -$8.1M | -$10.3M | |
| Cash From Financing | -$60.4M | -$232.7M | -$99.3M | -$25.5M | -$31.9M | |
| Free Cash Flow | $31.2M | $184M | $118.5M | $27.5M | $42.4M | |
BGS
Sector
Market Cap
$335.9M
$258.9M
Price % of 52-Week High
43.22%
75.55%
Dividend Yield
18.05%
0%
Shareholder Yield
--
2.89%
1-Year Price Total Return
-54.24%
-11.52%
Beta (5-Year)
0.742
0.392
Dividend yield:
18.05%
Annualized payout:
$0.76
Payout ratio:
-28.61%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$4.11
200-day SMA
Sell
Level
$7.08
Bollinger Bands (100)
Sell
Level
5.27 - 7.19
Chaikin Money Flow
Sell
Level
-27.4M
20-day SMA
Sell
Level
$4.62
Relative Strength Index (RSI14)
Sell
Level
32.55
ADX Line
Sell
Level
37.85
Williams %R
Neutral
Level
-66.1972
50-day SMA
Sell
Level
$5.82
MACD (12, 26)
Sell
Level
-0.56
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Sell
Level
-84.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0527)
Sell
CA Score
(Annual)
Level (-1.8005)
Buy
Beneish M-Score
(Annual)
Level (-2.9441)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.9182)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
B&G Foods Inc is an American packaged-food manufacturer. It operate in a single industry segment and manufacture, sell and distribute a diverse portfolio of high-quality shelf-stable and frozen foods across the United States, Canada and Puerto Rico. Its products include frozen and canned vegetables, vegetable, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, The company's main brands are Ac'cent, B&G, B&M, Baker's Joy, Bear Creek Country Kitchens, Cary's, Cream of Rice, Cream of Wheat, Devonsheer, Don Pepino, Durkee, Emeril's, Grandma's Molasses, MacDonald's.
Stock Forecast FAQ
In the current month, BGS has received 0 Buy ratings 5 Hold ratings, and 2 Sell ratings. The BGS average analyst price target in the past 3 months is $5.50.
-
Where Will B&G Foods Stock Be In 1 Year?
According to analysts, the consensus estimate is that B&G Foods share price will rise to $5.50 per share over the next 12 months.
-
What Do Analysts Say About B&G Foods?
Analysts are divided on their view about B&G Foods share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that B&G Foods is a Buy and believe this share price will drop from its current level to $7.00.
-
What Is B&G Foods's Price Target?
The price target for B&G Foods over the next 1-year time period is forecast to be $5.50 according to 7 Wall Street analysts, 0 of them rate the stock a Buy, 2 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is BGS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for B&G Foods is a Hold. 5 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BGS?
You can purchase shares of B&G Foods via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase B&G Foods shares.
-
What Is The B&G Foods Share Price Today?
B&G Foods was last trading at $4.21 per share. This represents the most recent stock quote for B&G Foods. Yesterday, B&G Foods closed at $4.21 per share.
-
How To Buy B&G Foods Stock Online?
In order to purchase B&G Foods stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
